SR-A, MARCO and TLRs differentially recognise selected surface proteins from neisseria meningitidis: An example of fine specificity in microbial ligand recognition by innate immune receptors

Journal of Innate Immunity

Volumn 1, Issue 2, 2009, Pages 153-163

  Plüddemann, Annette ^a   Mukhopadhyay, Subhankar ^a   Sankala, Marko ^b   Savino, Silvana ^c   Pizza, Mariagrazia ^c   Rappuoli, Rino ^c   Tryggvason, Karl ^b   Gordon, Siamon ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c CHIRON VACCINES   (Italy)

Author keywords

Cytokine; Ligand; Macrophage; Neisseria; Receptor collaboration; Scavenger receptor; Toll like receptor

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; BACTERIAL PROTEIN; LIGAND; MACROPHAGE RECEPTOR WITH A COLLAGENOUS STRUCTURE; MEMBRANE PROTEIN; MEMBRANE RECEPTOR; POLYANION; SCAVENGER RECEPTOR A; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR; MARCO PROTEIN, MOUSE; OUTER MEMBRANE PROTEIN;

AGONIST; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIUM DETECTION; CYTOKINE PRODUCTION; INNATE IMMUNITY; LIGAND BINDING; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; IMMUNOLOGY; KNOCKOUT MOUSE; MENINGOCOCCOSIS; METABOLISM; PERITONEUM MACROPHAGE;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; IMMUNITY, INNATE; LIGANDS; MACROPHAGES, PERITONEAL; MEMBRANE PROTEINS; MENINGOCOCCAL INFECTIONS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEISSERIA MENINGITIDIS; RECEPTORS, IMMUNOLOGIC; SCAVENGER RECEPTORS, CLASS A; TOLL-LIKE RECEPTORS;

EID: 67649394036     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000155227     Document Type: Article

References (59)

1. Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell 2006; 124:783-801.
2. Gordon S: Pattern recognition receptors: doubl ingup for the innate immune response. Cell 2002; 111:927-930.
3. Taylor PR, Martinez-Pomares L, Stacey M, Lin H-H, Brown GD, Gordon S: Macrophage receptors and immune recognition. Annu Rev Immunol 2005;23:901-944.
4. O'Neill LA: How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol 2006;18:3-9.
5. Krieger M: The other side of scavenger receptors: pattern recognition for host defense. Curr Opin Lipidol 1997;8:275-280.
6. Elomaa O, Sankala M, Pikkarainen T, Berg-mann U, Tuuttila A, Raatikainen-Ahokas A, Sariola H, Tryggvason K: Structure of the human macrophage MARCO receptor and characterization of its bacteria-binding region. J Biol Chem 1998;273:4530-4538.
7. Gough PJ, Greaves DR, Gordon S: A naturally occurring isoform of the human mac-rophage scavenger receptor (SR-A) gene generated by alternative splicing blocks modified LDL uptake. J Lipid Res 1998;39:531-543.
8. Matsumoto A, Naito M, Itakura H, Ikemoto S, Asaoka H, Hayakawa I, Ka namori H, Abu-ratani H, Takaku F, Suzuki H, et al: Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci USA 1990; 87: 9133-9137.
9. Rohrer L, Freeman M, Kodama T, Penman M, Krieger M: Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor ty pe II. Nature 1990; 343: 570 - 572.
10. Kodama T, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, Krieger M: Type I macro-phage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature 1990; 343:531-535.
11. Fraser I, Hughes D, Gordon S: Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature 1993;364:343- 346.
12. Ojala JR, Pikkarainen T, Tuuttila A, San-dalova T, Tryggvason K: Crystal structure of the cysteine-rich domain of scavenger receptor MARCO reveals the presence of a basic and an acidic cluster that both contribute to ligand recognition. J Biol Chem 2007;282: 16654-16666.
13. Becker M, Cotena A, Gordon S, Platt N: Expression of the class A macrophage scavenger receptor on specific subpopulations of murine dendritic cells limits their endotoxin response. Eur J Immunol 2006;36:950-960.
14. Hughes DA, Fraser IP, Gordon S: Murine macrophage scavenger receptor: in vivo expression and function as receptor for macro-phage adhesion in lymphoid and non-lym-phoid organs. Eur J Immunol 1995;25: 466-473.
15. Brown JM, Swindle EJ, Kushnir-Sukhov NM, Holian A, Metcalfe DD: Silica-directed mast cell activation is enhanced by scavenger receptors. Am J Respir Cell Mol Biol 2007; 36: 43-52.
16. Naito M, Suzuki H, Mori T, Matsumoto A, Kodama T, Takahashi K: Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions. Am J Pat hol 1992; 14 1:591-599.
17. van der Laan LJ, Kangas M, Dopp EA, Broug-Holub E, Elomaa O, Tryggvason K, Kraal G: Macrophage scavenger receptor MARCO: in vitro and in vivo regulation and involvement in the anti-bacterial host defense. Immunol Lett 1997; 57:203-208.
18. Doyle SE, O'Connell RM, Miranda GA, Vaidya SA, Chow EK, Liu PT, Suzuki S, Suzuki N, Modlin RL, Yeh WC, Lane TF, Cheng G: Toll-like receptors induce a phagocytic gene program through p38. J Exp Med 2004; 199:81-90.
19. de Villiers WJ, Fraser IP, Hughes DA, Doyle AG, Gordon S: Macrophage-colony-stimu-lating factor selectively enhances macro-phage scavenger receptor expression and f unction. J Exp Med 1994; 180:705-709.
20. Gough PJ, Gordon S: The role of scavenger receptors in the innate immune system. Microbes Infect 2000;2:305-11.
21. Plüddemann A, Neyen C, Gordon S: Macro-phage scavenger receptors and host-derived ligands. Methods 2007;43:207-217.
22. Plüddemann A, Mukhopadhyay S, Gordon S: The interaction of macrophage receptors with bacterial ligands. Expert Rev Mol Med 2006;8:1-25.
23. Chen Y, Sankala M, Ojala JRM, Sun Y, Tuut-tila A, Isenman DE, Tryggvason K, Pikkara-inen T: A phage display screen and binding studies with acetylated LDL provide evidence for the importance of the scavenger receptor cysteine-rich (SRCR) domain in the ligand-binding function of MARCO. J Biol Chem 2006;281;12767-12775.
24. Dunne DW, Resnick D, Greenberg J, Krieger M, Joiner KA: The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid. Proc Nat l Acad Sci USA, 1994;91:1863-1867.
25. Elomaa O, Kangas M, Sahlberg C, Tuukkanen J, Sormunen R, Liakka A, Thesleff I, Kraal G, Tryggvason K: Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell 1995;80:603-609.
26. Hampton RY, Golenbock DT, Penman M, Krieger M, Raetz CR: Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 1991;352:342-344.
27. Takeda K, Kaisho T, Akira S: Toll-like receptors. A nnu Rev Immunol 2003;21:335-376.
28. Marshall-Clarke S, Downes JE, Haga IR, Bowie AG, Borrow P, Pennock JL, Grencis RK, Rothwell P: Polyinosinic acid is a ligand for toll-like receptor 3. J Biol Chem 2007;282: 24759-24766.
29. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ: Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 2002; 105:1158-1161.
30. Hashimoto M, Tawaratsumida K, Kariya H, Kiyohara A, Suda Y, Krikae F, Kirikae T, Gotz F: Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologi-cally active compounds in Staphylococcus aureus. J Immunol 2006; 177:3162-3169.
31. Henneke P, Dramsi S, Mancuso G, Chraibi K, Pellegrini E, Theilacker C, Hubner J, Santos-Sierra S, Teti G, Golenbock DT, Poyart C, Trieu-Cuot P: Lipoproteins are critical TLR2 activating toxins in group B streptococcal sepsis. J Immunol 2008; 180:6149-6158.
32. da Silva Correia J, Soldau K, Christen U, Tobias PS, Ulevitch RJ: Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex transfer from CD14 to TLR4 and MD-2. J Biol Chem 2001; 276:21129-21135.
33. Dziarski R, Wang Q, Miyake K, Kirschning CJ, Gupta D: MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopoly-saccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components. J Immunol 2001; 166:1938-1944.
34. Dalpke A, Frank J, Peter M, Heeg K: Activation of toll-like receptor 9 by DNA from different bacterial species. Infect Immun 2006; 74:940-946.
35. Muk hopadhyay S, Chen Y, Sanka la M, Peiser L, Pikkarainen T, Kraal G, Tryggvason K, Gordon S: MARCO, an innate activation marker of macrophages, is a class A scavenger receptor for Neisseria meningitiDis. Eur J Immunol 2006;36:940-949.
36. Peiser L, de Winther MPJ, Makepeace K, Hollinshead M, Coull P, Plested J, Kodama T, Moxon ER, Gordon S: The class A macro-phage scavenger receptor is a major pattern recognition receptor for Neisseria meningiti-dis which is independent of lipopolysaccha-ride and not required for secretory responses. Infect Immun 2002;70:5346-5354.
37. Peiser L, Makepeace K, Plüddemann A, Sa-vino S, Wright JC, Pizza M, Rappuoli R, Moxon ER, Gordon S: Identification of Neis-seria meningitidis nonlipopolysaccharide li-gands for class A macrophage scavenger receptor by using a novel assay. Infect Immun 2006;74:5191-5199.
38. Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, Crozat K, Sovath S, Shamel L, Har-tung T, Zahringer U, Beutler B: CD36 is a sensor of diacylglycerides. Nature 2005;433: 523-527.
39. Jeannin P, Bottazzi B, Sironi M, Doni A, Rus-nati M, Presta M, Maina V, Magistrelli G, Haeuw JF, Hoeffel G, Thieblemont N, Cor-vaia N, Garlanda C, Delneste Y, Mantovani A: Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. Immunity 2005;22:551-560.
40. Butler PJG, Hartley BS: Maleylation of ami-no groups. Methods Enzymol 1972;25:191- 199.
41. van der Laan LJ, Dopp EA, Haworth R, Pik-karainen T, Kangas M, Elomaa O, Dijkstra CD, Gordon S, Tryggvason K, Kraal G: Regulation and functional involvement of mac-rophage scavenger receptor MARCO in clearance of bacteria in vivo. J Immunol 1999;162:939-947.
42. Pizza M, Scarlato V, Masignani V, Giuliani MM, Arico B, Comanducci M, Jennings GT, Baldi L, Bartolini E, Capecchi B, Galeotti CL, Luzzi E, Manetti R, Marchetti E, Mora M, Nuti S, Ratti G, Santini L, Savino S, Scar-selli M, Storni E, Zuo P, Broeker M, Hundt E, Knapp B, Blair E , Mason T, Tettelin H, Hood DW, Jeffries AC, Saunders NJ, Granoff DM, Venter JC, Moxon ER, Grandi G, Rappuoli R: Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000; 287:1816- 1820.
43. Chen Y, Pikkarainen T, Elomaa O, Soininen R, Kodama T, Kraal G, Tryggvason K: Defective microarchitecture of the spleen marginal zone and impaired response to a thymus-independent type 2 antigen in mice lacking scavenger receptors MARCO and SR-A. J Immunol 2005; 175:8173-8180.
44. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T, Takashima Y, Kawabe Y, Cynshi O, Wada Y, Honda M, Kurihara H, Aburatani H, Doi T, Matsumoto A, Azuma S, Noda T, Toyoda Y, Itakura H, Yazaki Y, Kodama T, et al: A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 1997; 386: 292-296.
45. Fauve RM, Jusforgues H, Hevin B: Maintenance of granuloma macrophages in serum-free medium. J Immunol Methods 1983;64: 345-351.
46. Rabinowitz S, Horstmann H, Gordon S, Griffiths G: Immunocytochemical characterization of the endocytic and phagolyso-somal compartments in peritoneal macro-phages. J Cell Biol 1992;116:95-112.
47. Plüddemann A, Neyen C , Gordon S, Peiser L: A sensitive solid-phase assay for identification of class A macrophage scavenger receptor ligands using cell lysate. J Immunol Methods 2008;329:167-175.
48. Sankala M, Brannstrom A, Schulthess T, Bergmann U, Morgunova E, Engel J, Tryg-gvason K, Pikkarainen T: Characterization of recombinant soluble macrophage scavenger receptor MARCO. J Biol Chem 2002;277: 33378-33385.
49. Goldstein JL, Ho YK, Basu SK, Brown MS: Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979; 76:333-337.
50. Raetz CR, Garrett TA, Reynolds CM, Shaw WA, Moore JD, Smith DC, Jr., Ribeiro AA, Murphy RC, Ulevitch RJ, Fearns C, Reichart D, Glass CK, Benner C, Subramaniam S, Harkewicz R, Bowers-Gentry RC, Buczynski MW, Cooper JA, Deems RA, Dennis EA: Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4. J Lipid Res 2006;47:1097-1111.
51. Coller SP, Paulnock DM: Signaling pathways initiated in macrophages after engagement of type A scavenger receptors. J Leukoc Biol 2001;70:142-148.
52. Greenberg JW, Fischer W, Joiner KA: Influence of lipoteichoic acid structure on recognition by the macrophage scavenger receptor. Infect Immun 1996;64:3318-3325.
53. Zhu FG, Reich CF, Pisetsky DS: The role of the macrophage scavenger receptor in immune stimulation by bacterial DNA and synthetic oligonucleotides. Immunology 2001; 103:226-234.
54. Jozefowski S, Sulahian TH, Arredouani M, Kobzik L: Role of scavenger receptor MARCO in macrophage responses to CpG oligo-deoxynucleotides. J Leukoc Biol 2006; 80: 870-879.
55. Hale CA, de Boer PA: Direct binding of FtsZ to ZipA, an essential component of the septal ring structure that mediates cell division in E. coli. Cell 1997;88:175-185.
56. Hsu HY, Chiu SL, Wen MH, Chen KY, Hua KF: Ligands of macrophage scavenger receptor induce cytokine expression via differential modulation of protein kinase signaling pathways. J Biol Chem 2001;276:28719- 28730.
57. Arredouani M, Yang Z , Ning Y, Qin G, Soin-inen R, Tryggvason K, Kobzik L: The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. J Exp Med 2004;200:267- 272.
58. Thomas CA, Li Y, Kodama T, Suzuki H, Sil-verstein SC, El Khoury J: Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis. J Exp Med 2000;191:147-156.
59. Zaks K, Jordan M, Guth A, Sellins K, Kedl R, Izzo A, Bosio C, Dow S: Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists com-plexed to cationic liposomes. J Immunol 2006;176:7335-7345.